Iomeron 200 mg/ml solution for injection Bulharsko - bulharčina - Изпълнителна агенция по лекарствата

iomeron 200 mg/ml solution for injection

bracco imaging s.p.a. - iomeprol - 200 mg/ml solution for injection

Iomeron 250 mg/ml solution for injection Bulharsko - bulharčina - Изпълнителна агенция по лекарствата

iomeron 250 mg/ml solution for injection

bracco imaging s.p.a. - iomeprol - 250 mg/ml solution for injection

Iomeron 300 mg/ml solution for injection Bulharsko - bulharčina - Изпълнителна агенция по лекарствата

iomeron 300 mg/ml solution for injection

bracco imaging s.p.a. - iomeprol - 300 mg/ml solution for injection

Iomeron 350 mg/ml solution for injection Bulharsko - bulharčina - Изпълнителна агенция по лекарствата

iomeron 350 mg/ml solution for injection

bracco imaging s.p.a. - iomeprol - 350 mg/ml solution for injection

Iomeron 400 mg/ml solution for injection Bulharsko - bulharčina - Изпълнителна агенция по лекарствата

iomeron 400 mg/ml solution for injection

bracco imaging s.p.a. - iomeprol - 400 mg/ml solution for injection

Iopamiro 300 mg/ml solution for injection  Bulharsko - bulharčina - Изпълнителна агенция по лекарствата

iopamiro 300 mg/ml solution for injection 

bracco imaging s.p.a. - iopamidol - 300 mg/ml solution for injection 

Iopamiro 370 mg/ml solution for injection  Bulharsko - bulharčina - Изпълнителна агенция по лекарствата

iopamiro 370 mg/ml solution for injection 

bracco imaging s.p.a. - iopamidol - 370 mg/ml solution for injection 

Ximluci Európska únia - bulharčina - EMA (European Medicines Agency)

ximluci

stada arzneimittel ag - ранимизумаб - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - Офталмологични - ximluci is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).

Resolor Európska únia - bulharčina - EMA (European Medicines Agency)

resolor

takeda pharmaceuticals international ag ireland - Сукцинат prucalopride - запек - Други лекарства за запек - resolor е показан за симптоматично лечение на хроничен констипация при възрастни, при които лаксативите не осигуряват адекватно облекчение.

Byooviz Európska únia - bulharčina - EMA (European Medicines Agency)

byooviz

samsung bioepis nl b.v. - ранимизумаб - wet macular degeneration; macular edema; diabetic retinopathy; myopia, degenerative - Офталмологични - byooviz is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).